Well + Good: Here’s What You Need To Know About the COVID-19 Antiviral Pills

Late last year, the U.S. Food and Drug Administration (FDA) authorized the first oral antiviral treatment for COVID-19. The emergency use authorization of the Pfizer-produced drug, Paxlovid, marked a significant turning point in national efforts to fight the virus.

Still, this encouraging news might have left you with a lot of lingering questions: What is the purpose of Paxlovid? Who’s authorized to take it? What are the limitations of the drug? Below, Lee Nguyen, PharmD, associate clinical professor of the Department of Clinical Pharmacy Practice at the UC Irvine College of Health Sciences, answers your COVID-19 antiviral pill questions.

Read the full article here.

Share This Post

Subscribe To Our Newsletter

Get updates From the UCI School of Pharmacy and Pharmaceutical Sciences

More To Explore

Clinical Pharmacy Practice

The Role of a Pharmacist in U.S. Travel Health

In an article published in an issue of Advancing Public Health Through Community Pharmacy Practice, Keri Hurley-Kim, discusses new guidance for pharmacists in travel health practice related to COVID-19.